EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TREM2 drives monocyte-derived macrophage responses to Cryptococcus neoformans

Adiza Abass, Alison Ricafrente, Apurwa Trivedi, Amy Vichaidit, Aelita Arshakyan, Sreemoyee Acharya, Lena J Heung iD

Infection and Immunity · 10.11.2026

DOI: 10.1128/iai.00364-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infection and Immunity, online erschienen am 10.11.2026. Verfasst von Adiza Abass und 6 weiteren Autor:innen. Beteiligte Einrichtung: Women's Guild Lung Institute, Cedars-Sinai Health Sciences University, Los Angeles, California, USA. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cryptococcus neoformans is an opportunistic fungus that can cause pulmonary and central nervous system infections after entry into the lungs. We previously established that signaling through the adapter protein DAP12 inhibits the antifungal response of monocyte-derived macrophages and worsens the survival of mice after C. neoformans infection. However, the molecular mechanisms by which DAP12 signaling is initiated during cryptococcosis remain inadequately characterized. In this study, we identify triggering receptor expressed on myeloid cells 2 (TREM2) as a DAP12-associated receptor that is induced on murine monocytes and interstitial macrophages in the lungs in response to C. neoformans infection. TREM2 subsequently represses fungal uptake and M1 polarization by monocyte-derived macrophages. Using an in vitro binding assay, we find that both murine and human TREM2 can directly bind to C. neoformans and that the absence of the cryptococcal cell wall antigen β-1,6-glucan disrupts these interactions. Overall, our findings suggest that the TREM2-DAP12 pathway plays an important inhibitory role in the host immune response to cryptococcal infection by impeding macrophage activation and phagocytosis of fungal cells. We also establish TREM2 as a receptor involved in direct fungal sensing of C. neoformans .

Schlagwörter

Stichwörter der Autor:innen

Cryptococcus neoformansDAP12TREM2fungal infectionmacrophagemonocyte

Autor:innen und Institutionen

  • Women's Guild Lung Institute, Cedars-Sinai Health Sciences University, Los Angeles, California, USA.
  • Department of Medicine, Cedars-Sinai Health Sciences University, Los Angeles, California, USA.
  • Department of Biomedical Sciences, Cedars-Sinai Health Sciences University, Los Angeles, California, USA.

ORCID-Profile: Lena J Heung

Förderung

  • NIAID NIH HHS
  • NHLBI NIH HHS
  • National Institutes of Health

Zitieren

APA

Abass, A., Ricafrente, A., Trivedi, A., Vichaidit, A., Arshakyan, A., Acharya, S., & Heung, L. J. (2026). TREM2 drives monocyte-derived macrophage responses to Cryptococcus neoformans. Infection and Immunity. https://doi.org/10.1128/iai.00364-26

Vancouver

Abass A, Ricafrente A, Trivedi A, Vichaidit A, Arshakyan A, Acharya S, et al. TREM2 drives monocyte-derived macrophage responses to Cryptococcus neoformans. Infection and Immunity. 2026. doi:10.1128/iai.00364-26

BibTeX
@article{Abass2026,
  author = {Abass, Adiza and Ricafrente, Alison and Trivedi, Apurwa and Vichaidit, Amy and Arshakyan, Aelita and Acharya, Sreemoyee and Heung, Lena J},
  title = {TREM2 drives monocyte-derived macrophage responses to Cryptococcus neoformans},
  journal = {Infection and Immunity},
  year = {2026},
  doi = {10.1128/iai.00364-26}
}
Kostenlos starten →